If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBio-Sustainable Future Enterprises Regulatory News (BSFA)

Share Price Information for Bio-Sustainable Future Enterprises (BSFA)

Share Price is delayed by 15 minutes
Get Live Data
0.90    -0.046 (-5.12%)
Bid:
0.80
Ask:
1.00
Spread: 0.20 (25.00%)
Market Cap: £1.65m
BSFA Live PriceLast checked at - London Stock Exchange

Intraday Bio-Sustainable Future Enterprises Share Chart

Strategic Investment

28 Apr 2025 10:01

RNS Number : 4243G
BSF Enterprise PLC
28 April 2025
 

London, 28 April 2025

 

BSF Enterprise PLC 

 

Strategic Investment

 

BSF Enterprise PLC ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that it has conditionally placed 4,725,000 new ordinary shares in the Company ("Placing Shares") raising ÂĢ141,750 at 3p per share in a placing ("Placing") within the Company's remaining headroom for shares available under the Financial Conduct's Authority Rules.

 

Shard Capital is acting as sole broker to the Company.

 

In light of the significant news on T-Rex leather last Friday we had some small additional headroom for investment and this fundraise represents continuing support from the Company's largest shareholder to bolster the Company's strategic business and growth plans, with the possibility of significant value inflection points throughout 2025.

 

Completion of the Placing is conditional on, inter alia, the Placing Shares being admitted to listing on the Equity Shares (transition) category of the Official List and to trading on the London Stock Exchange's main market for listed securities ("Admission"). Admission is expected before 15 May 2025.

 

Applications will be made to the FCA and to the London Stock Exchange for Admission in respect of all the Placing Shares proposed to be issued on completion of the Placing. 

 

The rights attaching to the Placing Shares will rank pari passu with the existing ordinary shares of the Company. This announcement contains inside information for the purposes of Article 7 of Regulation 2014/596/EU which is part of domestic UK law pursuant to the Market Abuse (Amendment) (EU Exit) regulations (SI 2019/310).

 

Contact Information For further information, please visit: www.bsfenterprise.com


 

For further enquiries, please visit www.bsfenterprise.com or contact:

BSF Enterprise PLC

 

 

Geoff Baker - Executive Director

Che Connon - CEO & Director

 

Shard Capital (Broker)

Damon Heath

Isabella Pierre

0207 186 9000

0207 186 9927

 

About BSF Enterprise PLC

BSF Enterprise PLC (BSF) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free platform, BSF aims to deliver sustainable alternatives to traditional materials and meet global demand for environmentally responsible innovations.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUWCCUPAURR
Date   Source Headline
30th Jun 20267:00 amRNSInterim 2026 Results
26th Jun 20267:00 amRNSBSF Wins Cannes 2026 Awards for T-Rex Leather
16th Jun 20267:00 amRNSAuction Operational Update & Strategic Progress
12th Jun 20267:00 amRNSParis Auction Result
11th Jun 20267:00 amRNS£1 Million Convertible Loan Note
8th Jun 202611:59 amRNSShareholder meeting results
3rd Jun 20267:00 amRNSConditional Further Investment
2nd Jun 20268:50 amRNSTechnical White Paper on T-Rex Leather™
28th May 20267:00 amRNSAuction Update - May 2026
26th May 20267:00 amRNSStrategic Update May 2026
22nd May 20263:13 pmRNSPosting of Circular and Notice of General Meeting
5th May 20267:00 amRNST-Rex Leather™ handbag to be auctioned
17th Apr 202610:00 amRNSAdmission of Shares
13th Apr 20267:00 amRNSStrategic Shareholding Update
7th Apr 20267:00 amRNSWorld’s First T-Rex Leather Handbag Unveiled
2nd Apr 20267:00 amRNSWorld First T-Rex Leather™ Product
19th Mar 20267:00 amRNSSupply Agreement with SeaWith
17th Mar 20267:00 amRNSLGL Tanning Milestones
17th Mar 20267:00 amRNSLGL Tanning Milestones
13th Mar 20267:00 amRNSFurther Update on Fundraise & Reorganisation
13th Mar 20267:00 amRNSFurther Update on Fundraise & Reorganisation
10th Mar 202610:47 amRNSFirst Tannable A4-Sized Skin Achieved
10th Mar 202610:47 amRNSFirst Tannable A4-Sized Skin Achieved
3rd Mar 202611:00 amRNSResult of Annual General Meeting
27th Feb 20267:00 amRNSUpdate on Proposed Equity Fundraise
9th Feb 20267:00 amRNSNotice of 2026 AGM
3rd Feb 20265:14 pmRNSAnnual Financial Report - Correction
2nd Feb 20267:00 amRNSAnnual Financial Report
19th Jan 20267:00 amRNSKERATO LIMITED SIGNS WITH QUEBEC PSO GRANT
17th Dec 202511:08 amRNSResult of General Meeting
16th Dec 20257:00 amRNS3D Bio-Tissues Signs Supply Agreement with SeaWith
15th Dec 20257:00 amRNSChanges to timetable for proposed Equity Fundraise
5th Dec 20259:50 amRNS-RBSF Enterprise launches new Investor website
1st Dec 20257:02 amRNSProposed Equity Fundraise - Strategic Direction
1st Dec 20257:00 amRNSEquity Fundraise & Notice of General Meeting
29th Aug 202510:47 amRNSResignation of Chairman
10th Jul 20257:00 amRNSAgreement
25th Jun 20257:00 amRNSInterim 2025 Results
23rd May 20257:00 amRNS15p Warrants Amended
21st May 20257:00 amRNSLab-Grown Leather Ltd Progress
28th Apr 202510:01 amRNSStrategic Investment
25th Apr 20259:48 amRNSJoint Venture
13th Mar 20257:00 amRNS3DBT Lab Grown Leather Commercialization
6th Mar 20253:51 pmRNSPublication of a Prospectus
5th Mar 202512:10 pmRNSResult of Annual General Meeting
11th Feb 20258:21 amRNSExpected admission of shares - Replacement
11th Feb 20257:00 amRNSAIM Admission - Update
10th Feb 20257:00 amRNSAGM Statement
31st Jan 202512:41 pmRNSAnnual Financial Report
31st Jan 202512:31 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.